Silvia Marino

16PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 19, 2025
The invasion phenotypes of glioblastoma depend on plastic and reprogrammable cell states.

Milena Doroszko, Rebecka Stockgard, Irem Uppman

|Apr 29, 2025
Disruption of DNA methylation underpins the neuroinflammation induced by targeted CNS radiotherapy.

Thomas O Millner, Pratistha Panday, Yunchen Xiao

|Apr 28, 2025
A novel model of glioblastoma recurrence to identify therapeutic vulnerabilities.

Sara Lucchini, James G Nicholson, Xinyu Zhang

|Aug 16, 2024
Unravelling the mosaic: Epigenetic diversity in glioblastoma.

Sara Lucchini, Myrianni Constantinou, Silvia Marino

|Nov 22, 2022
Global hypo-methylation in a proportion of glioblastoma enriched for an astrocytic signature is associated with increased invasion and altered immune landscape.

James Boot, Gabriel Rosser, Dailya Kancheva

|Jul 14, 2022
Subgroup-specific roles of primary cilia in medulloblastoma.

Silvia Marino

Pageof 3

Frequent Collaborators

6 joint publications

Sebastian Brandner

3 joint publications

Sara Badodi

3 joint publications

Sven Nelander

2 joint publications

Denise Sheer